On 12 April 2010 JSC “Grindeks” has received the notification on obtaining
significant holding from OJSC “Pharmstandart”. “Pharmstandart's” total holdings
in the security of JSC “Grindeks” currently amount to 11.3% of the outstanding
shares.
“Grindeks” Chairman of the Board Janis Romanovskis: “OJSC “Pharmstandart” is
the leading Russian pharmaceutical company and since 2008 is one of the most
important cooperation partners of “Grindeks” that promotes and sells our brand
product Mildrontate®. OJSC “Pharmstandart” as one of the biggest shareholders
of “Grindeks” will strengthen our positions in Russia and provide new business
opportunities.”
In the attachment: Notification from “Pharmstandart” on 4 (four) pages.
Further information:
Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
e-mail: laila.klavina@grindeks.lv
